CLL and SLL displayed the greatest response to combination therapy, with the levels of cytochrome c release significantly greater when compared to DLBCL (p = 0.0014 and 0.0011, Figure 4D). This evidence concerns the gene CYCS and B-cell chronic lymphocytic leukemia.